Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 15 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2010Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008)Simpson, M.; Dewey, H.; Churilov, L.; Ahmed, N.; Bladin, C.; Schultz, D.; Markus, R.; Sturm, J.; Levi, C.; Blacker, D.; Jannes, J.; Lindley, R.; Parsons, M.
2016Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trialZdenkowski, N.; Forbes, J.F.; Boyle, F.M.; Kannourakis, G.; Gill, P.G.; Bayliss, E.; Saunders, C.; Della-Fiorentina, S.; Kling, N.; Campbell, I.; Mann, G.B.; Coates, A.S.; Gebski, V.; Davies, L.; Thornton, R.; Reaby, L.; Cuzick, J.; Green, M.
2015Frailty in nursing homes: the FRAIL-NH scaleKaehr, E.; Visvanathan, R.; Malmstrom, T.K.; Morley, J.E.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2013Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS StudyChew, D.; French, J.; Briffa, T.; Hammett, C.; Ellis, C.; Ranasinghe, I.; Aliprandi-Costa, B.; Astley, C.; Turnbull, F.; Lefkovits, J.; Redfern, J.; Carr, B.; Gamble, G.; Lintern, K.; Howell, T.; Parker, H.; Tavella, R.; Bloomer, S.; Hyun, K.; Brieger, D.
2012Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2015Recent trends in early stage response to combination antiretroviral therapy in AustraliaMcManus, H.; Hoy, J.; Woolley, I.; Boyd, M.; Kelly, M.; Mulhall, B.; Roth, N.; Petoumenos, K.; Law, M.
2011Effect of dialysis modality on survival of hepatitis C-infected ESRF patientsBose, B.; McDonald, S.; Hawley, C.; Brown, F.; Badve, S.; Wiggins, K.; Bannister, K.; Boudville, N.; Clayton, P.; Johnson, D.